Related content and features

Pharmawire

Pharmawire, part of The Mergermarket Group of products, was launched in 2007 to publish real-time, forward looking news on the most price-sensitive issues in the global pharmaceutical and biotechnology markets.

Our specialist team of financial reporters and analysts generate proprietary intelligence on 4 core areas: product approvals, litigation, licensing deals, and M&A. In addition to this actionable intelligence Pharmawire provides financial professionals on the trading and advisory sides, with comprehensive data on over 10,000 individual drugs and details of associated licensing deals.

Pharmawire provides those in the pharmaceutical and biotechnology industries with the information, expert opinion and predictive intelligence needed to gain competitive advantages.

The service is delivered in real-time via the internet and email alerts.

To view all previous Pharmawire articles, please click here to go to the archive.

_____________________________________________________________

For more information

please email ft@Pharmawire.com
or call: Europe: 44 (0)20 7059 6202 USA: +1 212 500 134

_____________________________________________________________